Apr 22, 2021|
JD Health and GSK to Expand Cooperation
by Hui Zhang
Global pharmaceutical leader GlaxoSmithKline (GSK) announced plans to expand cooperation on consumer healthcare with JD Health on April 19, in the areas of technology, product and services.
“The health industry is not only a fast-growing industry, but also related to the dignity and quality of life of every person,” said Lijun Xin, CEO of JD Health. “Through this cooperation, JD Health will join hands with GSK Consumer Healthcare to continue promoting public healthcare management and providing one-stop solutions for consumers.”
Through the cooperation, GSK will create a variety of customized products for JD Health, which will also be the first platform in China to sell them, thus further enriching healthcare product categories on JD Health. In return, JD Health will leverage its own platform resources and supply chain capabilities to shorten the transaction process between products and consumers, and assist GSK’s consumer healthcare products’ sales online.
Susan Gu, greater China general manager at GSK Consumer Healthcare, said GSK has witnessed the tremendous impact of digitalization on the healthcare ecosystem in recent years. “The scenarios and channels through which consumers access healthcare services are undergoing a profound digital transformation,” Gu said. “The pandemic has not only accelerated the process, but has also raised national health awareness like never before, making consumers more focused on long-term health management.”
As a research-driven pharmaceutical and healthcare company, GSK Consumer Healthcare is fully engaged in digital healthcare development, Gu added.
“This in-depth collaboration with JD Health is an important step in our digital transformation process. We hope that by joining forces with JD Health, we can work together to build a digital, sustainable health ecosystem that will help achieve our vision of providing innovative health solutions to every Chinese consumer to help them improve their quality of life.”
It’s not the first time for JD Health and GSK to deepen bilateral cooperation. The two companies signed a memorandum last year to deepen collaboration on vaccinations. The two sides will explore new vaccination supply and service solutions based on the strength of the Internet and other technologies to provide premium and safe vaccinations, and make them accessible to a wider range of people in China.
GSK is a science-led global healthcare company. The company researches, develops and manufactures a wide range of medicines, vaccines and consumer healthcare products.